Fast Unsupervised Brain Anomaly Detection and Segmentation with Diffusion Models
Deep generative models have emerged as promising tools for detecting arbitrary anomalies in data, dispensing with the necessity for manual labelling. Recently, autoregressive transformers have achieved state-of-the-art performance for anomaly detection in medical imaging. Nonetheless, these models s...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Deep generative models have emerged as promising tools for detecting
arbitrary anomalies in data, dispensing with the necessity for manual
labelling. Recently, autoregressive transformers have achieved state-of-the-art
performance for anomaly detection in medical imaging. Nonetheless, these models
still have some intrinsic weaknesses, such as requiring images to be modelled
as 1D sequences, the accumulation of errors during the sampling process, and
the significant inference times associated with transformers. Denoising
diffusion probabilistic models are a class of non-autoregressive generative
models recently shown to produce excellent samples in computer vision
(surpassing Generative Adversarial Networks), and to achieve log-likelihoods
that are competitive with transformers while having fast inference times.
Diffusion models can be applied to the latent representations learnt by
autoencoders, making them easily scalable and great candidates for application
to high dimensional data, such as medical images. Here, we propose a method
based on diffusion models to detect and segment anomalies in brain imaging. By
training the models on healthy data and then exploring its diffusion and
reverse steps across its Markov chain, we can identify anomalous areas in the
latent space and hence identify anomalies in the pixel space. Our diffusion
models achieve competitive performance compared with autoregressive approaches
across a series of experiments with 2D CT and MRI data involving synthetic and
real pathological lesions with much reduced inference times, making their usage
clinically viable. |
---|---|
DOI: | 10.48550/arxiv.2206.03461 |